134 related articles for article (PubMed ID: 1374506)
1. Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron aging.
Pasinetti GM; Osterburg HH; Kelly AB; Kohama S; Morgan DG; Reinhard JF; Stellwagen RH; Finch CE
Brain Res Mol Brain Res; 1992 Mar; 13(1-2):63-73. PubMed ID: 1374506
[TBL] [Abstract][Full Text] [Related]
2. Alterations in tyrosine hydroxylase expression following partial lesions of the nigrostriatal bundle.
Sherman TG; Moody CA
Brain Res Mol Brain Res; 1995 Apr; 29(2):285-96. PubMed ID: 7609616
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
Matsuura K; Makino H; Ogawa N
Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
[TBL] [Abstract][Full Text] [Related]
4. Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain.
Zhou FC; Bledsoe S; Murphy J
Brain Res; 1991 Aug; 556(1):108-16. PubMed ID: 1718555
[TBL] [Abstract][Full Text] [Related]
5. Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain.
Blanchard V; Chritin M; Vyas S; Savasta M; Feuerstein C; Agid Y; Javoy-Agid F; Raisman-Vozari R
J Neurochem; 1995 Apr; 64(4):1669-79. PubMed ID: 7891094
[TBL] [Abstract][Full Text] [Related]
6. Chronic lesions differentially decrease tyrosine hydroxylase messenger RNA in dopaminergic neurons of the substantia nigra.
Pasinetti GM; Lerner SP; Johnson SA; Morgan DG; Telford NA; Finch CE
Brain Res Mol Brain Res; 1989 May; 5(3):203-9. PubMed ID: 2566883
[TBL] [Abstract][Full Text] [Related]
7. Acute and repeated administration of fluphenazine-N-mustard alters levels of tyrosine hydroxylase mRNA in subsets of mesencephalic dopaminergic neurons.
Weiss-Wunder LT; Chesselet MF
Neuroscience; 1992 Jul; 49(2):297-305. PubMed ID: 1359452
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of the levels of tyrosine hydroxylase and preproenkephalin mRNAs in nigrostriatal sites after 6-hydroxydopamine lesions.
Zhu YS; Jones SB; Burke RE; Franklin SO; Inturrisi CE
Life Sci; 1993; 52(19):1577-84. PubMed ID: 8097862
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
10. Morphological and biochemical adaptations to unilateral dopamine denervation of the neostriatum in newborn rats.
Penit-Soria J; Durand C; Herve D; Besson MJ
Neuroscience; 1997 Apr; 77(3):753-66. PubMed ID: 9070750
[TBL] [Abstract][Full Text] [Related]
11. Histamine infusion induces a selective dopaminergic neuronal death along with an inflammatory reaction in rat substantia nigra.
Vizuete ML; Merino M; Venero JL; Santiago M; Cano J; Machado A
J Neurochem; 2000 Aug; 75(2):540-52. PubMed ID: 10899929
[TBL] [Abstract][Full Text] [Related]
12. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra.
Ichitani Y; Okamura H; Nakahara D; Nagatsu I; Ibata Y
Exp Neurol; 1994 Dec; 130(2):269-78. PubMed ID: 7867756
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic stimulation of substantia nigra: abolition of carbachol-induced eating by unilateral 6-hydroxydopamine lesion of nigrostriatal dopamine neurones.
Parker GC; Rugg EL; Winn P
Exp Brain Res; 1991; 87(3):597-603. PubMed ID: 1723691
[TBL] [Abstract][Full Text] [Related]
15. Disappearance of GAD-mRNA and tyrosine hydroxylase in substantia nigra following striatal ibotenic acid lesions: evidence for transneuronal regression.
Pasinetti GM; Morgan DG; Finch CE
Exp Neurol; 1991 May; 112(2):131-9. PubMed ID: 1674692
[TBL] [Abstract][Full Text] [Related]
16. The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation.
Yamamoto T; Uchiyama T; Sakakibara R; Taniguchi J; Kuwabara S
Neuroscience; 2014 Feb; 259():43-52. PubMed ID: 24291727
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine hydroxylase as a target for deltamethrin in the nigrostriatal dopaminergic pathway.
Liu GP; Ma Q; Shi N
Biomed Environ Sci; 2006 Feb; 19(1):27-34. PubMed ID: 16673815
[TBL] [Abstract][Full Text] [Related]
18. GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats.
Goettl VM; Wemlinger TA; Duchemin AM; Neff NH; Hadjiconstantinou M
Neuroscience; 1999; 92(3):991-1000. PubMed ID: 10426539
[TBL] [Abstract][Full Text] [Related]
19. In vivo electrochemical measurements and electrophysiological studies of rat striatum following neonatal 6-hydroxydopamine treatment.
Luthman J; Friedemann M; Bickford P; Olson L; Hoffer BJ; Gerhardt GA
Neuroscience; 1993 Feb; 52(3):677-87. PubMed ID: 7680793
[TBL] [Abstract][Full Text] [Related]
20. Lesions of nigrostriatal pathway reduce expression of tyrosine hydroxylase gene in residual dopaminergic neurons of substantia nigra.
Shirao T; Evinger MJ; Iacovitti L; Reis DJ
Neurosci Lett; 1992 Jul; 141(2):208-12. PubMed ID: 1359468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]